Ftse Mib
33.423,57
-1,08%
DAX
19.744,56
-1,27%
S&P 500
5.867,08
0,00%
NASDAQ
19.372,77
0,00%
Bitcoin
94.946,03
-2,60%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ MaxCyte Inc (MXCT) MaxCyte Inc (MXCT) Notizie

MaxCyte Inc

MXCT
4,01
-0,13 (-3,14%)
Pre Mercato
Ultimo aggiornamento: 13:55:14
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/12/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202414:01EDGAR2Form 8-K - Current report
09/12/202408:00GLOBEMaxCyte Announces Streamlined Operations and Raises 2024..
14/11/202401:14EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202414:05GLOBEMaxCyte Celebrates 25 Years of Innovation Driving Cell..
08/11/202423:31EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
06/11/202422:55EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202422:22EDGAR2Form 8-K - Current report
06/11/202422:05GLOBEMaxCyte Reports Third Quarter 2024 Financial Results and..
05/11/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202421:23EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
31/10/202413:05GLOBEMaxCyte to Participate in Two Upcoming Investor Conferences
30/10/202421:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202423:32EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/10/202422:40EDGAR2Form 8-K - Current report
15/10/202414:05GLOBEMaxCyte Appoints Cynthia Collins to its Board of Directors
11/10/202414:05GLOBEMaxCyte to Report Third Quarter 2024 Financial Results on..
10/10/202414:05GLOBEMaxCyte Appoints Ali Soleymannezhad as Chief Commercial..
02/10/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/9/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202422:11EDGAR2Form 144 - Report of proposed sale of securities
18/9/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202422:28EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/9/202408:00GLOBEMaxCyte Signs Strategic Platform License with Kamau..
05/9/202422:05GLOBEMaxCyte to Participate in Virtual Craig-Hallum Capital Group..
03/9/202422:36EDGAR2Form 144 - Report of proposed sale of securities
28/8/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/8/202422:55EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202422:13EDGAR2Form 8-K - Current report
06/8/202422:05GLOBEMaxCyte Reports Second Quarter and Half-Year 2024 Financial..
06/8/202400:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/7/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/7/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/7/202422:05GLOBEMaxCyte to Report Second Quarter 2024 Financial Results on..
13/6/202423:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202423:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:45EDGAR2Form 8-K - Current report
10/6/202423:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202414:05GLOBEMaxCyte to Participate in William Blair 44th Annual Growth..
22/5/202414:05GLOBEMaxCyte Signs Strategic Platform License Agreement with..
07/5/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:14EDGAR2Form 8-K - Current report
07/5/202422:05GLOBEMaxCyte Reports First Quarter 2024 Financial Results and..
10/4/202414:05GLOBEMaxCyte to Report First Quarter 2024 Financial Results on..
02/4/202414:05GLOBEMaxCyte Signs Strategic Platform License with Be Biopharma..
Apertura: Min: Max:
Chiusura: 4,14

La tua Cronologia

NASDAQ
MXCT
MaxCyte
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network